|
ERK5-IN-1 XMD 8-85
|
ERK5-IN-1
|
1234479-76-5
|
|
COH000
|
(1R,4S)-二甲基1-((R)-1-(苯基氨基)-2-(對甲苯基)乙基)-7-氧雜二環(huán)[2.2.1]庚-2,5-二烯-2,3-二羧酸
|
1534358-79-6
|
|
A2764 dihydrochloride - TRESK inhibitor A2764
|
A2764 鹽酸鹽
|
861038-72-4
|
|
Ansofaxine (hydrochloride),LY03005
|
5-氨基-1,3-二苯基吡唑
|
916918-84-8
|
|
A -30
|
酪氨酸磷酸化抑制劑 AG 30
|
122520-79-0
|
|
XMD16-5
|
2-((4-(4-羥基哌啶-1-基)苯基)氨基)-11-甲基-5H-苯并[E]嘧啶并[5,4-B][1,4]二氮雜卓-6(11H)-酮
|
1345098-78-3
|
|
2-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-1H-BENZIMIDAZOLE TRIHYDROCHLORIDE
|
ABT-724游離
|
70006-24-5
|
|
Rimeporide
|
EMD-87580
|
187870-78-6
|
|
1M7
|
1-METHYL-7-NITRO-2H-3,1-BENZOXAZINE-2,4(1H)-DIONE
|
73043-80-8
|
|
LC3-mHTT-IN-1
|
(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one
|
486443-73-6
|
|
BYK204165
|
4-((1-甲基-1H-吡咯-2-基)亞甲基)異喹啉-1,3(2H,4H)-二酮
|
1104546-89-5
|
|
NSC 185058
|
N-(吡啶-2-基)吡啶-2-硫代甲酰胺
|
39122-38-8
|
|
Raphin1
|
(E)-3-[(2,3-二氯苯基)亞甲基]氨基胍
|
2022961-17-5
|
|
D3-βArr- NC C 00379308
|
2-甲氧基-4-(4-甲基哌嗪-1-基)苯胺
|
662164-09-2
|
|
LRRK2-IN-1
|
5,11-二氫-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮雜卓-6-酮
|
1234480-84-2
|
|
DG172 (dihydrochloride)
|
D 172鹽酸鹽
|
1361504-77-9
|
|
2-[[4-(2-Pyridinyl)-1-piperazinyl]Methyl]-1H-benziMidazole trihydrochloride
|
ABT-724鹽
|
587870-77-7
|
|
RPW-24
|
RPW-24
|
1001625-82-6
|
|
R 13022
|
RG-13022
|
136831-48-6
|
|
eA69
|
N-(2-(9H-咔唑-1-基)苯基)乙酰胺
|
2143475-98-1
|
|
RN 1734
|
2,4-二氯-N-(異丙基)-N-[2-[(異丙基)氨基]乙基]苯磺酰胺
|
946387-07-1
|
|
(rac)-Antineoplaston A10
|
3-苯基乙酰氨基-2,6-哌啶二酮
|
77658-84-5
|
|
MDL-100009
|
(-)-MDL 100907
|
175673-57-1
|
|
PBD-150
|
PBD-150
|
790663-33-1
|
|
AUDA
|
AUDA
|
479413-70-2
|
|
DAAO inhibitor-1
|
DAAO inhibitor-1
|
2065250-25-9
|
|
VU0810464
|
VU0810464
|
2126040-21-7
|
|
INH14
|
INH14
|
200134-22-1
|
|
JNJ 5207852
|
化合物JNJ-5207852
|
398473-34-2
|
|
INDIRUBIN-3'-MONOXIME
|
Indirubin-3'-monoxime (靛玉紅-3”-単肟）
|
160807-49-8
|
|
Volinanserin
|
139290-65-6
|
139290-65-6
|
|
MPO-IN-28
|
MPO-IN-28
|
37836-90-1
|
|
XMD8-87
|
5,11-二氫-2-((2-甲氧基-4-(4-甲基-1-哌嗪基)苯基)氨基)-11-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮雜卓-6-酮
|
1234480-46-6
|
|
PK150
|
PK150
|
2165324-62-7
|
|
BTZO-1
|
BTZO 1
|
99420-15-2
|
|
sis17
|
SIS17
|
2374313-54-7
|
|
SKA-31
|
NAPHTHO[1,2-D]THIAZOL-2-AMINE
|
40172-65-4
|
|
TLX a onist 1
|
TLX agonist 1
|
958323-31-4
|
|
W 284543 hydrochloride
|
6,7-二甲氧基-N-(3-苯氧基苯基)喹啉-4-胺鹽酸鹽
|
179246-08-3
|
|
CM10
|
2-(prop-2-en-1-yl)-6-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol
|
692269-09-3
|
|
A2793
|
2-[(5-氯-8-喹啉基)氧基]乙酸乙酯
|
88349-90-0
|
|
RHC80267
|
1,6-雙(環(huán)己基脒基羰基氨基)己烷
|
83654-05-1
|
|
RSVA 405
|
化合物RSVA 405
|
140405-36-3
|
|
FPL 62064
|
N-(4-甲氧苯基)-1-苯基-1H-吡唑-3-胺
|
103141-09-9
|
|
ADH-503
|
ADH-503;ADH503;ADH 503
|
2055362-74-6
|
|
MIFOBATE
|
米福貝特
|
76541-72-5
|
|
VU0134992(hydrochloride)
|
VU0134992鹽酸鹽
|
1052515-91-9
|
|
Enoximone
|
Enoximone依諾昔酮
|
77671-31-9
|
|
MLS000532223
|
1-(3-硝基苯基)-3-苯基丙-2-炔-1-酮
|
16616-39-0
|
|
APX-115 free base
|
APX-115 freebase
|
1270084-92-8
|
|
SC560
|
5-(4-氯苯基)-1-(4-甲氧基苯基)-3-(三氟甲基)-1H-吡唑
|
188817-13-2
|
|
DCLK1-IN-1
|
DCLK1-IN-1
|
2222635-15-4
|
|
MMP-9-IN-1
|
MMP-9-IN-1
|
502887-71-0
|
|
MDV3100 carboxylic acid
|
恩雜魯胺羧酸
|
1242137-15-0
|
|
4-IPP
|
4-IODO-6-PHENYLPYRIMIDINE
|
41270-96-6
|
|
AA147
|
N-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide
|
393121-74-9
|
|
ILK-IN-3
|
4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine
|
6975-75-3
|
|
4-CMTB
|
4-Chloro-α-(1-methylethyl)-N-2-thiazolyl-benzeneacetamide
|
300851-67-6
|
|
AKR1C1-IN-1
|
3-bromo-5-phenyl Salicylic Acid
|
4906-68-7
|
|
COH-SR4
|
COH-SR4
(Mitochondria uncoupler SR4)
|
73439-19-7
|
|
Myoseverin
|
肌基質蛋白
|
267402-71-1
|
|
SP141
|
6-甲氧基-1-(萘-1-基)-9H-吡啶并[3,4-B]吲哚
|
1253491-42-7
|
|
DHODH-IN-11
|
DHODH-IN-11
|
1263303-95-2
|
|
I S-1.76
|
化合物IGS-1.76
|
313480-47-6
|
|
VUT-MK142
|
化合物VUT-MK142
|
1313491-22-3
|
|
NS1652
|
NS1652
|
1566-81-0
|
|
XP-59
|
XP-59
|
890402-73-0
|
|
IRAK4-IN-4
|
IRAK4-IN-4
|
1850276-58-2
|
|
Filastatin
|
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone
|
431996-53-1
|
|
ML406
|
化合物ML406
|
774589-47-8
|
|
Anisindione
|
茴茚二酮
|
117-37-3
|
|
Ikixi
|
2-(2-氰基乙?；?-N-(3,4-二氯苯基)肼基硫代甲酰胺
|
656222-54-7
|
|
bay474
|
化合物BAY-474
|
1033767-86-0
|
|
YM-58483
|
YM-5883
|
223499-30-7
|
|
BD750
|
2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol
|
892686-59-8
|
|
PFDHODH-IN-2
|
2-[((4-氯苯基)氨基]-4-氧代-4,5-二氫噻吩-3-羧酸乙酯
|
425629-94-3
|
|
IQ3
|
IQ 3
|
312538-03-7
|
|
PSEM 89S TFA
|
化合物PSEM 89S TFA
|
1336913-03-1
|
|
TBOPP
|
TBOPP
|
1996629-79-8
|
|
MID1
|
4-乙氧基-N-(5-硝基噻唑-2-基)苯甲酰胺
|
312608-54-1
|
|
PT R2-IN-22 PT R2-IN-1
|
1-(4-(2-甲氧基苯基)哌嗪-1-基)-2-苯基乙酮
|
349093-44-3
|
|
cpypp
|
4-[3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione
|
310460-39-0
|
|
camalexin
|
CAMALEXIN
|
135531-86-1
|
|
pu02
|
PU-02; PU02
|
313984-77-9
|
|
ESI-05
|
ESI-05
|
5184-64-5
|
|
(R)-P7C3-OMe
|
(R)-1-(3,6-二溴-9H-咔唑-9-基)-3-(3-甲氧基苯基氨基)丙烷-2-醇
|
1235481-43-2
|
|
Euquinine
|
無味奎寧
|
83-75-0
|
|
LCH-7749944
|
LCH-7749944
|
796888-12-5
|
|
1-(3,6-dibromocarbazol-9-yl)-3-(3-methoxyanilino)propan-2-ol
|
P7C3-Ome 消旋
|
313268-18-7
|
|
Apcin A
|
Apcin-A
|
1683617-62-0
|
|
MS7972
|
化合物MS7972
|
352553-42-5
|
|
Bohemine
|
BOHEMINE
|
189232-42-6
|
|
SC-58125
|
1-[(4-甲基磺?；?苯基]-3-三氟甲基-5-(4-氟苯基)吡唑
|
162054-19-5
|
|
FIDAS-5
|
FIDAS-5
|
1391934-98-7
|
|
CID-25014542 Raf inhibitor 2
|
220904-99-4
|
220904-99-4
|
|
MitoBloCK-11 (MB-11)
|
2-((4-溴萘-1-基)氧基)-N'-((5-硝基噻吩-2-基)亞甲基)乙酰肼
|
413606-16-3
|
|
ICCB280
|
(E)-2-(3,4-二羥基苯乙烯基)-3-(2-甲氧基苯基)喹唑啉-4(3H)-酮
|
2041072-41-5
|
|
NS-6180
|
NS-6180
|
353262-04-1
|
|
J 113863
|
1,4-CIS-1-(1-CYCLOOCTEN-1-YLMETHYL)-4-[[(2,7-DICHLORO-9H-XANTHEN-9-YL)CARBONYL]AMINO]-1-ETHYLPIPERIDINIUM IODIDE
|
353791-85-2
|
|
ALLO-2
|
ALLO-2
(Smo inhibitor ALLO-2)
|
1357350-60-7
|